News ArticleHCL Technologies to Engage Investors at Three Major Conferences in November 2026
Company executives to hold one-on-one investor meetings during JM Financial, CLSA, and Morgan Stanley events
HCL Technologies Ltd. announced its participation in multiple investor conferences including JM Financial Annual India Conference, CLSA India Forum, and Morgan Stanley Asia Pacific Summit in November 2026. Company executives will engage with investors on one-on-one basis without sharing any unpublished price sensitive information.
HCL Technologies Ltd.
General / Other
HCL Technologies Ltd. will participate in prominent investor conferences in November 2026, including JM Financial Annual India Conference, CLSA India Forum, and Morgan Stanley’s Asia Pacific Summit, to meet with investors individually.
The company confirmed its attendance at three important investor events held in Mumbai and Singapore from November 16 to 19, 2026.
At these events, executives are scheduled to conduct one-on-one meetings with investors to discuss company-related topics without disclosing any unpublished price sensitive information.
The specific events include the JM Financial Annual India Conference - India Xchange 2026 and the 29th CITIC CLSA India Forum in Mumbai, followed by Morgan Stanley's Twenty-Fifth Annual Asia Pacific Summit in Singapore.
Highlights
- Participation dates: November 16-19, 2026.
- Locations: Mumbai, India and Singapore.
- Events: JM Financial Annual India Conference, 29th CITIC CLSA India Forum, Morgan Stanley Asia Pacific Summit.
- Company executives to meet investors one-on-one without sharing unpublished price sensitive information.
Key Data Snapshot
What happened
- HCL Technologies Ltd. announced participation in three investor conferences in November 2026.
- Company executives will engage in one-on-one meetings with some investors at these events.
- No unpublished price sensitive information will be shared during these meetings.
Key details
- JM Financial Annual India Conference - India Xchange 2026 will be held in Mumbai from November 16 to 18, 2026.
- The 29th CITIC CLSA India Forum 2026 will also take place in Mumbai from November 16 to 18, 2026.
- Morgan Stanley's Twenty-Fifth Annual Asia Pacific Summit will be held in Singapore from November 18 to 19, 2026.
Highlights
- Participation dates: November 16-19, 2026.
- Locations: Mumbai, India and Singapore.
- Events: JM Financial Annual India Conference, 29th CITIC CLSA India Forum, Morgan Stanley Asia Pacific Summit.
- Company executives to meet investors one-on-one without sharing unpublished price sensitive information.
Disclosures
- Listing Obligations and Disclosure Requirements Regulations
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
Biocon Limited Reports Q2 FY2027 Profit of Rs. 917 Million and Announces New CTO Appointment
Biocon Limited disclosed its unaudited standalone financial results for the quarter and half year ending September 30, 2026, with a quarterly profit of Rs. 917 million. The board also approved the resignation of CTO Dr. Mandar Shrikant Ghatnekar effective December 31, 2026, and the appointment of Mr. Mukesh Rathi as CTO starting January 1, 2027.
Read Full Story
Biocon Reports Q2 FY27 Total Income of Rs 4,423 Crore With Biopharma Revenue Up 5% and $400 Million Pertuzumab Deal
Biocon Limited announced consolidated total income of Rs 4,423 crore for the second quarter of fiscal year 2027, with biopharma revenues increasing by 5% year-on-year to Rs 3,583 crore. The company's EBITDA was reported at Rs 865 crore and net profit at Rs 41 crore. A significant highlight includes securing a 10-year biosimilar Pertuzumab PDP partnership in Brazil valued at about USD 400 million.
Read Full Story
Zydus Lifesciences Posts Rs. 79,096 Million Revenue in Q2 FY27 with Net Profit at Rs. 9,255 Million
Zydus Lifesciences Limited reported strong revenue growth of 29% year-on-year in Q2 FY27 at Rs. 79,096 million, driven by its branded pharma businesses in India, North America, and international markets. However, net profit declined 27% to Rs. 9,255 million, and EBITDA dropped 6% to Rs. 18,945 million, reflecting cost and margin pressures.
Read Full Story
